Clinical Trial Update: Olaparib in Treating Patients With Stage IV Pancreatic Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated olaparib in patients with Stage IV pancreatic cancer, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-10-01